Literature DB >> 26454663

Immunogenic properties of a trimeric gp41-based immunogen containing an exposed membrane-proximal external region.

Habtom H Habte1, Saikat Banerjee1, Heliang Shi1, Yali Qin1, Michael W Cho2.   

Abstract

The membrane-proximal external region (MPER) of HIV-1 gp41 is an attractive target for vaccine development. Thus, better understanding of its immunogenic properties in various structural contexts is important. We previously described the crystal structure of a trimeric protein complex named gp41-HR1-54Q, which consists of the heptad repeat regions 1 and 2 and the MPER. The protein was efficiently recognized by broadly neutralizing antibodies. Here, we describe its immunogenic properties in rabbits. The protein was highly immunogenic, especially the C-terminal end of the MPER containing 4E10 and 10E8 epitopes ((671)NWFDITNWLWYIK(683)). Although antibodies exhibited strong competition activity against 4E10 and 10E8, neutralizing activity was not detected. Detailed mapping analyses indicated that amino acid residues critical for recognition resided on faces of the alpha helix that are either opposite of or perpendicular to the epitopes recognized by 4E10 and 10E8. These results provide critical information for designing the next generation of MPER-based immunogens.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HIV-1; Immunogenicity; MPER; Rabbit; Vaccine; gp41

Mesh:

Substances:

Year:  2015        PMID: 26454663      PMCID: PMC4679429          DOI: 10.1016/j.virol.2015.09.010

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  89 in total

1.  Antibody 8ANC195 reveals a site of broad vulnerability on the HIV-1 envelope spike.

Authors:  Louise Scharf; Johannes F Scheid; Jeong Hyun Lee; Anthony P West; Courtney Chen; Han Gao; Priyanthi N P Gnanapragasam; René Mares; Michael S Seaman; Andrew B Ward; Michel C Nussenzweig; Pamela J Bjorkman
Journal:  Cell Rep       Date:  2014-04-24       Impact factor: 9.423

2.  Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers.

Authors:  Claudia Blattner; Jeong Hyun Lee; Kwinten Sliepen; Ronald Derking; Emilia Falkowska; Alba Torrents de la Peña; Albert Cupo; Jean-Philippe Julien; Marit van Gils; Peter S Lee; Wenjie Peng; James C Paulson; Pascal Poignard; Dennis R Burton; John P Moore; Rogier W Sanders; Ian A Wilson; Andrew B Ward
Journal:  Immunity       Date:  2014-04-24       Impact factor: 31.745

3.  Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimers.

Authors:  Emilia Falkowska; Khoa M Le; Alejandra Ramos; Katie J Doores; Jeong Hyun Lee; Claudia Blattner; Alejandro Ramirez; Ronald Derking; Marit J van Gils; Chi-Hui Liang; Ryan Mcbride; Benjamin von Bredow; Sachin S Shivatare; Chung-Yi Wu; Po-Ying Chan-Hui; Yan Liu; Ten Feizi; Michael B Zwick; Wayne C Koff; Michael S Seaman; Kristine Swiderek; John P Moore; David Evans; James C Paulson; Chi-Huey Wong; Andrew B Ward; Ian A Wilson; Rogier W Sanders; Pascal Poignard; Dennis R Burton
Journal:  Immunity       Date:  2014-04-24       Impact factor: 31.745

4.  Eliciting neutralizing antibodies with gp120 outer domain constructs based on M-group consensus sequence.

Authors:  Yali Qin; Marisa Banasik; SoonJeung Kim; Adam Penn-Nicholson; Habtom H Habte; Celia LaBranche; David C Montefiori; Chong Wang; Michael W Cho
Journal:  Virology       Date:  2014-08       Impact factor: 3.616

5.  A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals.

Authors:  D R Burton; C F Barbas; M A Persson; S Koenig; R M Chanock; R A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

6.  Induction of mucosal and systemic neutralizing antibodies against human immunodeficiency virus type 1 (HIV-1) by oral immunization with bovine Papillomavirus-HIV-1 gp41 chimeric virus-like particles.

Authors:  Hongtao Zhang; Yujun Huang; Raja Fayad; Gregory T Spear; Liang Qiao
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

7.  Chemically modified peptides based on the membrane-proximal external region of the HIV-1 envelope induce high-titer, epitope-specific nonneutralizing antibodies in rabbits.

Authors:  Vincent J Venditto; Lindsay Wieczorek; Sebastian Molnar; Fernando Teque; Gary Landucci; Douglas S Watson; Donald Forthal; Victoria R Polonis; Jay A Levy; Francis C Szoka
Journal:  Clin Vaccine Immunol       Date:  2014-05-28

8.  A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1.

Authors:  M Purtscher; A Trkola; G Gruber; A Buchacher; R Predl; F Steindl; C Tauer; R Berger; N Barrett; A Jungbauer
Journal:  AIDS Res Hum Retroviruses       Date:  1994-12       Impact factor: 2.205

9.  Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization.

Authors:  A Buchacher; R Predl; K Strutzenberger; W Steinfellner; A Trkola; M Purtscher; G Gruber; C Tauer; F Steindl; A Jungbauer
Journal:  AIDS Res Hum Retroviruses       Date:  1994-04       Impact factor: 2.205

10.  Development and immunological assessment of VLP-based immunogens exposing the membrane-proximal region of the HIV-1 gp41 protein.

Authors:  Thomas D Benen; Paul Tonks; Alexander Kliche; Ruth Kapzan; Jonathan L Heeney; Ralf Wagner
Journal:  J Biomed Sci       Date:  2014-08-27       Impact factor: 8.410

View more
  5 in total

1.  Evaluation of a novel multi-immunogen vaccine strategy for targeting 4E10/10E8 neutralizing epitopes on HIV-1 gp41 membrane proximal external region.

Authors:  Saikat Banerjee; Heliang Shi; Marisa Banasik; Hojin Moon; William Lees; Yali Qin; Andrew Harley; Adrian Shepherd; Michael W Cho
Journal:  Virology       Date:  2017-02-23       Impact factor: 3.616

2.  Modulating immunogenic properties of HIV-1 gp41 membrane-proximal external region by destabilizing six-helix bundle structure.

Authors:  Saikat Banerjee; Heliang Shi; Habtom H Habte; Yali Qin; Michael W Cho
Journal:  Virology       Date:  2016-01-21       Impact factor: 3.616

3.  Myomedin scaffold variants targeted to 10E8 HIV-1 broadly neutralizing antibody mimic gp41 epitope and elicit HIV-1 virus-neutralizing sera in mice.

Authors:  Milan Kuchař; Petr Kosztyu; Veronika Daniel Lišková; Jiří Černý; Hana Petroková; Eliška Vróblová; Michal Malý; Lucie Vaňková; Michal Křupka; Leona Rašková Kafková; Pavlína Turánek Knotigová; Jarmila Dušková; Jan Dohnálek; Josef Mašek; Jaroslav Turánek; Milan Raška; Petr Malý
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

Review 4.  The development of HIV vaccines targeting gp41 membrane-proximal external region (MPER): challenges and prospects.

Authors:  Huan Liu; Xiaojie Su; Lulu Si; Lu Lu; Shibo Jiang
Journal:  Protein Cell       Date:  2018-04-17       Impact factor: 14.870

5.  Artificial Anti-HIV-1 Immunogen Comprising Epitopes of Broadly Neutralizing Antibodies 2F5, 10E8, and a Peptide Mimic of VRC01 Discontinuous Epitope.

Authors:  Andrey P Rudometov; Anton N Chikaev; Nadezhda B Rudometova; Denis V Antonets; Alexander A Lomzov; Olga N Kaplina; Alexander A Ilyichev; Larisa I Karpenko
Journal:  Vaccines (Basel)       Date:  2019-08-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.